Search

everythinglearnresearchcommunity

for

Search:↓

Squaric acid dibutylester helps hair growth by increasing certain immune cells in the skin.

Stem cells can move to brain injury sites and be tracked, showing promise for treating brain diseases.

Removing GRK2 in skin cells causes hair loss similar to immune-related alopecia.

EGF and KGF signalling prevent hair follicle formation and promote skin cell development in mice.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Merkel cells develop independently of nerves and are linked to specific hair follicles in mice.

EGFR deficiency causes significant changes in skin cells and hair follicles.

Stem cells can be used to create long-lasting skin cells for treating pigment disorders.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Squaric acid dibutylester promotes hair growth by activating immune cells, especially macrophages.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

A new mouse model effectively mimics vitiligo for research and drug testing.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Matrical tumors share a common growth mechanism involving the Wnt pathway and consistent PHLDA1 expression.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Human thymus has stem cells that can self-renew and maintain their identity.

New method efficiently isolates hair growth cells from newborn mouse skin.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Human hair follicle stem cells can become endothelial cells with certain growth factors, useful for vascular treatments.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

ISX-9 helps stem cells heal lung injury better by boosting growth factor secretion.

Entospletinib effectively prevents eye and skin GVHD in mice.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Inhibiting TYK2 can restore hair growth in alopecia areata.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.